A novel CXCR4-selective high-affinity fluorescent probe and its application in competitive binding assays

Yilei Yang1, Qinghao Zhang, Mei Gao

  • 1Department of Pharmacology, Upstate Medical University, State University of New York , Syracuse, New York 13210, United States.

Biochemistry
|July 25, 2014
PubMed
Summary

Researchers created a novel bioassay using a fluorescent probe (DV1) that effectively blocks CXCR4 receptor binding. This rapid, specific system offers a new platform for drug screening and probe development.

Related Concept Videos